Personalized medicine: A pediatric perspective

被引:0
|
作者
Daniel Arnold
Bridgette L. Jones
机构
[1] University of Missouri-Kansas City,Children’s Mercy Hospital and Clinics Kansas City, Department of Pediatrics, School of Medicine
来源
关键词
Asthma; Atopic Dermatitis; Allergic Rhinitis; Allergy Clin Immunol; Montelukast;
D O I
暂无
中图分类号
学科分类号
摘要
The aim of pediatric personalized medicine is to uniquely combine genetic variation with developmental stage and environmental exposure to provide a tailored preventive, diagnostic, and therapeutic regimen. Recent advances in genomic research have identified many genetic variants that may be related to allergic and inflammatory disease and therapeutic response. These include variants involved in immune response, barrier proteins, and medication response. Current evidence also suggests that the effect of genetic variation often depends on the developmental stage of a child and environmental exposure such as infection or tobacco smoke during a specific stage. Personalized medicine is a new and exciting field with the potential to significantly improve medical care for children and adults.
引用
收藏
页码:426 / 432
页数:6
相关论文
共 50 条
  • [21] Personalized medicine: a perspective on the patient, disease and causal diagnostics
    Liebman, Michael N.
    [J]. PERSONALIZED MEDICINE, 2007, 4 (02) : 171 - 174
  • [22] CURRENT STATUS AND PERSPECTIVE OF PERSONALIZED MEDICINE IN DRUG DEVELOPMENT
    Nagumo, Akira
    [J]. DRUG METABOLISM REVIEWS, 2015, 47 : 27 - 28
  • [23] Legal and ethical concerns in personalized medicine: a European perspective
    Regniault, Alexandre
    Kupecz, Andras
    Gavey, Michael
    Mignolet, Olivier
    De Carlo, Paolo
    Meyer, Peter
    Bailey, Sarah
    [J]. PERSONALIZED MEDICINE, 2009, 6 (05) : 517 - 528
  • [24] Genomic and Personalized Medicine Perspective in Genetic Generalized Epilepsy
    Torabian, Pedram
    Dehestani, Mohamad
    Rad, Dorsa Morshedi
    Peiravi, Shima
    Aghaie-Hakkak, Mohsen
    Ashraf, Hami
    [J]. ARCHIVES OF IRANIAN MEDICINE, 2019, 22 (09) : 516 - 526
  • [25] Implications of personalized medicine—perspective from a cancer center
    Thomas Tursz
    Fabrice Andre
    Vladimir Lazar
    Ludovic Lacroix
    Jean-Charles Soria
    [J]. Nature Reviews Clinical Oncology, 2011, 8 : 177 - 183
  • [26] FROM PHARMACOGENETICS TO PERSONALIZED MEDICINE: A CUBAN REGULATORY PERSPECTIVE
    Remirez, D.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 83 - 83
  • [27] Lifetime experiences, the brain and personalized medicine: An integrative perspective
    McEwen, Bruce S.
    Getz, Linn
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2013, 62 (01): : S20 - S26
  • [28] The promise and the challenge of personalized medicine: A patient advocate perspective
    Scroggins, Mary Jackson
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2014, 23 (11)
  • [29] Personalized Medicine in Ovarian Cancer: A Perspective From Mexico
    Fernandez-Garza, Luis E.
    Dominguez-Vigil, Irma G.
    Garza-Martinez, Jose
    Valdez-Aparicio, Erick A.
    Barrera-Barrera, Silvia A.
    Barrera-Saldana, Hugo A.
    [J]. WORLD JOURNAL OF ONCOLOGY, 2021, 12 (04) : 85 - 92
  • [30] Border Medicine: The Pediatric Cardiology Perspective
    Ashutosh Agrawal
    Sethuraman Swaminathan
    Suvarna L. Guvvala
    Sudheer R. Gorla
    [J]. Pediatric Cardiology, 2020, 41 : 202 - 205